For research use only. Not for therapeutic Use.
MD 780236(Cat No.:I031703)is a small molecule inhibitor designed to target the protein kinase A (PKA) pathway, which plays a crucial role in regulating cellular processes such as metabolism, cell growth, and response to stress. By modulating PKA activity, MD 780236 has potential applications in treating diseases where this pathway is dysregulated, including cancer, cardiovascular disorders, and metabolic diseases like diabetes. Early studies suggest it may help in managing tumor growth and inflammation. However, further research and clinical trials are necessary to fully evaluate its therapeutic efficacy, safety, and potential applications in various diseases.
Catalog Number | I031703 |
CAS Number | 73423-36-6 |
Synonyms | MD 780236; MD780236; MD-780236; |
Molecular Formula | C18H19ClN2O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-(methylaminomethyl)-1,3-oxazolidin-2-one |
InChI | InChI=1S/C18H19ClN2O3/c1-20-10-17-11-21(18(22)24-17)15-5-7-16(8-6-15)23-12-13-3-2-4-14(19)9-13/h2-9,17,20H,10-12H2,1H3 |
InChIKey | KYXSTSXVEXKFJI-UHFFFAOYSA-N |
SMILES | CNCC1CN(C(=O)O1)C2=CC=C(C=C2)OCC3=CC(=CC=C3)Cl |